Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Consensus Rating of “Buy” by Analysts

Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) have been given a consensus rating of “Buy” by the sixteen research firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, eleven have assigned a buy rating and four have assigned a strong buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $48.9167.

Several research firms have recently issued reports on SRRK. Piper Sandler reduced their target price on Scholar Rock from $52.00 to $51.00 and set an “overweight” rating for the company in a report on Wednesday, September 24th. Leerink Partnrs upgraded Scholar Rock to a “strong-buy” rating in a research note on Monday, September 15th. Bank of America assumed coverage on Scholar Rock in a research report on Thursday, October 9th. They set a “buy” rating and a $53.00 target price for the company. JPMorgan Chase & Co. boosted their price target on shares of Scholar Rock from $46.00 to $47.00 and gave the stock an “overweight” rating in a report on Tuesday, November 18th. Finally, Truist Financial reduced their price target on shares of Scholar Rock from $54.00 to $44.00 and set a “buy” rating for the company in a research report on Monday, October 20th.

Insider Buying and Selling

In related news, Director Katie Peng sold 1,006 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The stock was sold at an average price of $44.09, for a total value of $44,354.54. Following the transaction, the director owned 32,908 shares in the company, valued at approximately $1,450,913.72. This represents a 2.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mo Qatanani sold 136,462 shares of the stock in a transaction on Thursday, December 4th. The shares were sold at an average price of $45.21, for a total value of $6,169,447.02. Following the transaction, the insider directly owned 108,964 shares of the company’s stock, valued at approximately $4,926,262.44. This trade represents a 55.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 13.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Scholar Rock by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 4,914,927 shares of the company’s stock worth $183,032,000 after acquiring an additional 53,333 shares during the period. Wellington Management Group LLP boosted its position in Scholar Rock by 124.5% during the third quarter. Wellington Management Group LLP now owns 4,545,887 shares of the company’s stock worth $169,289,000 after purchasing an additional 2,521,022 shares during the period. Bellevue Group AG increased its stake in shares of Scholar Rock by 10.1% in the third quarter. Bellevue Group AG now owns 3,244,537 shares of the company’s stock worth $120,827,000 after purchasing an additional 297,242 shares in the last quarter. Eventide Asset Management LLC raised its position in shares of Scholar Rock by 9.5% in the second quarter. Eventide Asset Management LLC now owns 2,913,246 shares of the company’s stock valued at $103,192,000 after purchasing an additional 251,638 shares during the period. Finally, Holocene Advisors LP purchased a new stake in shares of Scholar Rock during the 3rd quarter valued at approximately $91,670,000. Hedge funds and other institutional investors own 91.08% of the company’s stock.

Scholar Rock Stock Down 3.4%

SRRK opened at $41.31 on Wednesday. Scholar Rock has a fifty-two week low of $22.71 and a fifty-two week high of $48.28. The firm has a market capitalization of $4.21 billion, a P/E ratio of -13.11 and a beta of 0.63. The company’s 50-day moving average is $39.90 and its 200 day moving average is $36.45. The company has a debt-to-equity ratio of 0.41, a current ratio of 6.30 and a quick ratio of 6.30.

Scholar Rock (NASDAQ:SRRK) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.90) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.88) by ($0.02). During the same period last year, the company earned ($0.66) EPS. Research analysts expect that Scholar Rock will post -2.42 earnings per share for the current fiscal year.

About Scholar Rock

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).